Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAP for warts and molluscum in children
NCT05070754Phase 4Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2021
- Primary completion
- Dec 2022
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in verruca vulgaris and molluscum contagiosum (MC) (3 arms), sponsored by Medical University of South Carolina. Primary endpoints: Numbers of Lesions With no Response at 12 weeks, Numbers of Lesions With Partial Response at 12 weeks and 1 more. Started Dec 2021; status: completed.
02
Conditions
verruca vulgarismolluscum contagiosum (MC)
Beyond the preview
Go deeper on NCT05070754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05070754.